ClearPath Diagnostics offers a variety of special tests to enable our clients to provide the highest quality patient care.

ThinPrep® Pap specimens are approved for testing with the the Hologic Gen-Probe® APTIMA® HPV assay for Human papillomavirus (HPV) testing which targets E6/E7 mRNA to test for 14 high risk HPV types. Furthermore, the APTIMA HPV 16 18/45 genotype assay individually identifies and differentiates high risk types 16 and 18/45 which show higher carcinogenic potential relative to all other high risk HPV types. This test can be performed from the ThinPrep specimen vial, and is FDA approved. ThinPrep Pap specimens must be less than four weeks old. HPV testing can be done reflexively on all ThinPrep Pap samples. There must be sufficient quantity remaining after processing the pap test to perform the testing. Also, tissue specimens (paraffin embedded) can be tested for high and low risk HPV using in situ hybridization. Tissue specimens are stable indefinitely.

Neisseria gonorrhea, Chlamydia trachomatis and Trichomonas vaginalis
ClearPath offers Neisseria gonorrhoeae and Chlamydia trachomatis testing using the highly sensitive Hologic Gen-Probe® APTIMA Combo 2® Assay and Trichomonas vaginalis testing using the Hologic Gen-Probe APTIMA Trichomonas vaginalis Assay. These tests can be done using the ThinPrep liquid Pap specimen that is also sent for Pap and HPV analysis. This method allows us to provide up to 5 results (Pap, HPV, GC/Chlamydia and Trichomonas) from a single specimen, minimizing specimen handling for collection and transportation. To do these tests in conjunction with a ThinPrep Pap, they must be ordered along with the Pap. GC/Chlamydia and Trichomonas testing cannot be performed after the aliquot for the Pap test has been taken from the vial. Specimen collection and transport information for Neisseria gonorrhoeae, Chlamydia trachomatis and Trichomonas vaginalis testing can be found here. We provide the collection and transport material.

In addition to ThinPrep Pap specimens, the assay can also be performed on urine specimens (female and male), vaginal and endocervical swabs and male urethral swab specimens. We provide the collection and transport material.

We offer triple testing using Becton Dickinson Affirm VPIII to differentiate and identify three vaginitis pathogens: Candida species, Gardnerella vaginalis, and Trichomonas vaginalis. This analysis requires a separate vaginal swab. We provide the special swabs and transport system for this test. The test that comprise the AffirmTM Panel cannot be ordered individually from this test.

Molecular Diagnostic-PCR Testing
We offer molecular diagnostic testing through an exclusive arrangement with Medical Diagnostic Laboratories. This advanced polymerase chain reaction (PCR) technique provides a highly sensitive and specific test for numerous pathogens. All tests can be performed from one specimen, collected with MDL's OneSwab®.

Group B Streptococcus Testing
ClearPath Diagnostics is the first in the region to offer the illumigene® test for Group B Streptococcus (GBS). This new assay is the next generation of technology for GBS testing, replacing the current culture methodology. This broth-enriched molecular assay provides a rapid report with higher sensitivity compared to culture. The test is ideally suited for testing in late pregnancy.

HSV 1&2 Testing We offer the illumigene® HSV 1&2 test. This innovative molecular test provides highly sensitive and specific, rapid results and differentiates between HSV 1&2 on both mucocutaneous and cutaneous specimens. These specimens should be kept refrigerated prior to laboratory pick-up. We provide the collection swabs and transport materials.

We offer the Vysis UroVysion test for superior non-invasive assessment of patients with hematuria suspected of having bladder cancer and patients requiring subsequent monitoring for recurrence following previously diagnosed bladder cancer. This in situ immunofluorescent technique combines genomic DNA probe analysis with direct morphologic observation and provides greater sensitivity with fewer false negatives. Results are either positive or negative; there are no atypical, suspicious diagnoses.

We offer a full array of state-of-the-art immunohistochemistry antibodies. This specialized study of tissue and cells is presented to establish diagnoses with full histology technical support. It can be provided with interpretation as a consultation case or without as technical-only services. Click here for a list of available immunostains.

In Situ Hybridization
We offer in situ HPV analysis on tissue for both high and low risk subtypes and Her-2/neu by FISH (fluorescence in situ hybridization).
ClearPath Diagnostics  600 East Genesee Street, Suite 305,  Syracuse, NY 13202
Phone: (315) 234-3300  Toll Free: (866) 310-2406  Fax: (315) 234-3305
Copyright © 2018, ClearPath Diagnostics. All Rights Reserved.
Privacy Policy